Literature DB >> 26527716

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.

Michael J Ackerman, Douglas P Zipes, Richard J Kovacs, Barry J Maron.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; Brugada syndrome; athletes; cardiovascular abnormalities; channelopathies; heart rhythm disorders; long QT syndrome

Mesh：

Year:  2015        PMID： 26527716     DOI： 10.1161/CIR.0000000000000246

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  13 in total

Review 1.  The renal plumbing system: aquaporin water channels.

Authors:  L N Nejsum
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

2.  Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities.

Authors:  C N Lang; J Steinfurt; K E Odening
Journal:  Herz       Date:  2017-04       Impact factor: 1.443

Review 3.  Sudden Cardiac Death in the Young.

Authors:  Michael Ackerman; Dianne L Atkins; John K Triedman
Journal:  Circulation       Date:  2016-03-08       Impact factor: 29.690

Review 4.  Empowerment of athletes with cardiac disorders: a new paradigm.

Authors:  Rui Providencia; Carina Teixeira; Oliver R Segal; Augustus Ullstein; Kim Mueser; Pier D Lambiase
Journal:  Europace       Date:  2018-08-01       Impact factor: 5.214

5.  Is it time to loosen the restrictions on athletes with cardiac disorders competing in sport?

Authors:  Rui Providência; Carina Teixeira; Oliver Segal; Augustus Ullstein; Kim T Mueser; Pier Lambiase
Journal:  Br J Sports Med       Date:  2017-04-28       Impact factor: 13.800

6.  Turkish Society of Cardiology consensus report on recommendations for athletes with high-risk genetic cardiovascular diseases or implanted cardiac devices.

Authors:  Erdem Özel; Mustafa Feridun Koşar; Emin Evren Ozcan; Burak Hünük; Taner Ulus; Vedat Aytekin; Aylin Yildirir; Bülent Özin; Izzet Erdinler; Ömer Akyürek
Journal:  Anatol J Cardiol       Date:  2019-09       Impact factor: 1.596

7.  Significance of Exercise-Related Ventricular Arrhythmias in Patients With Brugada Syndrome.

Authors:  Hiroshi Morita; Saori T Asada; Masakazu Miyamoto; Yoshimasa Morimoto; Tomonari Kimura; Tomofumi Mizuno; Koji Nakagawa; Atsuyuki Watanabe; Nobuhiro Nishii; Hiroshi Ito
Journal:  J Am Heart Assoc       Date:  2020-11-23       Impact factor: 5.501

8.  Successful Management of a Young Athlete with Type 2 Long QT Syndrome by Genotype-specific Risk Stratification and Bridging Therapy with a Wearable Cardioverter Defibrillator.

Authors:  Katsumi Kojima; Koichi Kato; Yusuke Fujii; Yusuke Okuyama; Seiko Ohno; Tomoya Ozawa; Minoru Horie; Yoshihisa Nakagawa
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282

Review 9.  Catecholaminergic polymorphic ventricular tachycardia: An exciting new era.

Authors:  Shashank P Behere; Steven N Weindling
Journal:  Ann Pediatr Cardiol       Date:  2016 May-Aug

Review 10.  Athletes with channelopathy may be eligible to play.

Authors:  N M Panhuyzen-Goedkoop; A A M Wilde
Journal:  Neth Heart J       Date:  2018-03       Impact factor: 2.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.